{"id":"https://openalex.org/W1577485693","doi":"https://doi.org/10.21236/ada417775","title":"Development of an Oral Barley Beta-Glucan Adjuvant That Augments the Tumoricidal Activity of Antibodies or Vaccines Used for the Immunotherapy of Breast Cancer","display_name":"Development of an Oral Barley Beta-Glucan Adjuvant That Augments the Tumoricidal Activity of Antibodies or Vaccines Used for the Immunotherapy of Breast Cancer","publication_year":2003,"publication_date":"2003-07-01","ids":{"openalex":"https://openalex.org/W1577485693","doi":"https://doi.org/10.21236/ada417775","mag":"1577485693"},"language":"en","primary_location":{"id":"doi:10.21236/ada417775","doi":"https://doi.org/10.21236/ada417775","is_oa":false,"landing_page_url":"http://doi.org/10.21236/ada417775","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"US Dept of the Army","raw_type":"report"},"volume":null,"type":"report","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5111446242","display_name":"Gordon D. Ross","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":true,"raw_author_name":"Gordon D. Ross","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":["https://openalex.org/A5111446242"],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":null,"last_page":null},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10580","display_name":"Immunotherapy and Immune Responses","score":0.9932000041007996,"subfield":{"id":"https://openalex.org/subfields/2403","display_name":"Immunology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11016","display_name":"Monoclonal and Polyclonal Antibodies Research","score":0.0017000000225380063,"subfield":{"id":"https://openalex.org/subfields/2741","display_name":"Radiology, Nuclear Medicine and Imaging"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10158","display_name":"Cancer Immunotherapy and Biomarkers","score":0.0007999999797903001,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/adjuvants","display_name":"adjuvants","score":0.8510000109672546},{"id":"https://openalex.org/keywords/breast-cancer-immunotherapy","display_name":"breast cancer immunotherapy","score":0.8859999775886536},{"id":"https://openalex.org/keywords/antitumor-antibodies","display_name":"anti-tumor antibodies","score":0.8109999895095825},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.9430000185966492},{"id":"https://openalex.org/keywords/cetuximab","display_name":"cetuximab","score":0.9919999837875366},{"id":"https://openalex.org/keywords/complement-activation","display_name":"complement activation","score":0.7940000295639038},{"id":"https://openalex.org/keywords/tumor-regression","display_name":"tumor regression","score":0.9259999990463257},{"id":"https://openalex.org/keywords/vaccine-adjuvants","display_name":"vaccine adjuvants","score":0.6150000095367432}],"concepts":[{"id":"https://openalex.org/C2777863537","wikidata":"https://www.wikidata.org/wiki/Q357896","display_name":"Adjuvant","level":2,"score":0.762479305267334},{"id":"https://openalex.org/C2777701055","wikidata":"https://www.wikidata.org/wiki/Q1427096","display_name":"Immunotherapy","level":3,"score":0.6964458227157593},{"id":"https://openalex.org/C159654299","wikidata":"https://www.wikidata.org/wiki/Q79460","display_name":"Antibody","level":2,"score":0.6295010447502136},{"id":"https://openalex.org/C3018710434","wikidata":"https://www.wikidata.org/wiki/Q1641412","display_name":"Oral immunotherapy","level":4,"score":0.5923129320144653},{"id":"https://openalex.org/C2780674031","wikidata":"https://www.wikidata.org/wiki/Q2012719","display_name":"Cancer immunotherapy","level":4,"score":0.5792058706283569},{"id":"https://openalex.org/C2776123893","wikidata":"https://www.wikidata.org/wiki/Q416796","display_name":"Glucan","level":2,"score":0.5616548657417297},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.5173682570457458},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4648420214653015},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.45487627387046814},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.434002548456192},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.37061238288879395},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.33239567279815674},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.2999489903450012},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.2055259644985199},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.05461239814758301}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.21236/ada417775","doi":"https://doi.org/10.21236/ada417775","is_oa":false,"landing_page_url":"http://doi.org/10.21236/ada417775","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"US Dept of the Army","raw_type":"report"},{"id":"pmh:ADA417775","doi":null,"is_oa":false,"landing_page_url":"http://oai.dtic.mil/oai/oai?&verb=getRecord&metadataPrefix=html&identifier=ADA417775","pdf_url":null,"source":{"id":"https://openalex.org/S4406923043","display_name":"Defense Technical Information Center (DTIC)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"DTIC AND NTIS","raw_type":"Text"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":3,"referenced_works":["https://openalex.org/W1616668006","https://openalex.org/W2127971370","https://openalex.org/W2132252339"],"related_works":["https://openalex.org/W2108093856","https://openalex.org/W2149569216","https://openalex.org/W1616668006","https://openalex.org/W2010570889","https://openalex.org/W7100702498","https://openalex.org/W2123578853","https://openalex.org/W7096338771","https://openalex.org/W2084796607","https://openalex.org/W4313335792","https://openalex.org/W3030727566"],"abstract_inverted_index":{"These":[0],"Data":[1],"provided":[2],"strong":[3],"evidence":[4],"for":[5,13],"the":[6,38],"efficacy":[7],"of":[8,30,41],"an":[9],"oral":[10,42,70],"beta-glucan":[11],"adjuvant":[12],"use":[14],"in":[15],"combination":[16],"with":[17],"anti-tumor":[18],"antibodies":[19,33,48,59],"such":[20],"as":[21],"Herceptin,":[22],"Rituxan,":[23],"and":[24,52],"Erbitux.":[25],"The":[26,44],"tumor":[27],"regression":[28],"activity":[29],"these":[31],"three":[32],"was":[34],"significantly":[35],"increased":[36],"by":[37],"simultaneous":[39],"administration":[40],"beta-glucan.":[43,71],"data":[45],"showing":[46],"that":[47,58,60],"must":[49],"activate":[50,64],"complement":[51,65],"deposit":[53],"iC3b":[54],"on":[55],"tumors":[56],"means":[57],"do":[61],"not":[62,67],"to":[63],"would":[66],"benefit":[68],"from":[69]},"counts_by_year":[],"updated_date":"2026-08-26T07:47:46.906454","created_date":"2016-06-24T00:00:00"}